Dr Ing Valuation

DRPRY Stock   6.08  0.08  1.30%   
At this time, the firm appears to be undervalued. Dr Ing hc owns a latest Real Value of USD6.55 per share. The recent price of the firm is USD6.08. Our model computes the value of Dr Ing hc from reviewing the firm fundamentals such as Number Of Employees of 36.52 K, operating margin of 0.20 %, and Book Value Per Share of 25.19 X as well as analyzing its technical indicators and probability of bankruptcy.
Undervalued
Today
6.08
Please note that Dr Ing's price fluctuation is somewhat reliable at this time. Calculation of the real value of Dr Ing hc is based on 3 months time horizon. Increasing Dr Ing's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Dr Ing is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DRPRY Pink Sheet. However, Dr Ing's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  6.08 Real  6.55 Hype  6.08
The intrinsic value of Dr Ing's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Dr Ing's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
6.54
Real Value
8.84
Upside
Estimating the potential upside or downside of Dr Ing hc helps investors to forecast how DRPRY pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Dr Ing more accurately as focusing exclusively on Dr Ing's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
3.796.088.37
Details

Dr Ing Total Value Analysis

Dr Ing hc is currently projected to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Dr Ing fundamentals before making investing decisions based on enterprise value of the company

Dr Ing Investor Information

The company had not issued any dividends in recent years. Based on the key indicators obtained from Dr Ing's historical financial statements, Dr Ing hc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.

Dr Ing Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of DRPRY suggests not a very effective usage of assets in November.

Dr Ing Profitability Analysis

The company reported the revenue of 36.76 B. Net Income was 4.03 B with profit before overhead, payroll, taxes, and interest of 8.99 B.

About Dr Ing Valuation

Our relative valuation model uses a comparative analysis of Dr Ing. We calculate exposure to Dr Ing's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Dr Ing's related companies.

8 Steps to conduct Dr Ing's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Dr Ing's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Dr Ing's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Dr Ing's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Dr Ing's revenue streams: Identify Dr Ing's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Dr Ing's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Dr Ing's growth potential: Evaluate Dr Ing's management, business model, and growth potential.
  • Determine Dr Ing's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Dr Ing's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Dr Ing Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Retained Earnings9.1 B

Additional Tools for DRPRY Pink Sheet Analysis

When running Dr Ing's price analysis, check to measure Dr Ing's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Ing is operating at the current time. Most of Dr Ing's value examination focuses on studying past and present price action to predict the probability of Dr Ing's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Ing's price. Additionally, you may evaluate how the addition of Dr Ing to your portfolios can decrease your overall portfolio volatility.